AAAAAA

   
Results: 1-25 | 26-50 | 51-55
Results: 1-25/55

Authors: HIDALGO M RODRIGUEZ G KUHN JG BROWN T WEISS G MACGOVREN JP VONHOFF DD ROWINSKY EK
Citation: M. Hidalgo et al., A PHASE-I AND PHARMACOLOGICAL STUDY OF THE GLUTAMINE ANTAGONIST ACIVICIN WITH THE AMINO-ACID SOLUTION AMINOSYN IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, Clinical cancer research, 4(11), 1998, pp. 2763-2770

Authors: CASTELLANO D LIANES P PAZARES L HIDALGO M GUERRA JA GOMEZMARTIN C GOMEZ H CALZAS J CORTESFUNES H
Citation: D. Castellano et al., A PHASE-II STUDY OF A NOVEL GEMCITABINE PLUS CISPLATIN REGIMEN ADMINISTERED EVERY 3 WEEKS FOR ADVANCED NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 9(4), 1998, pp. 457-459

Authors: HIDALGO M VILLALONACALERO MA ECKHARDT SG WEISS G CAMPBELL E KRAYNAK M BEIJNEN J JIMENO J VONHOFF D ROWINSKY E
Citation: M. Hidalgo et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ET-743, A NOVEL MINOR-GROOVE BINDER OF MARINE ORIGIN ADMINISTERED ON A DAILY X 5 SCHEDULE, Annals of oncology, 9, 1998, pp. 613-613

Authors: HAMMOND L VILLALONACALERO M ECKHARDT SG SIU L HIDALGO M THORNTON D WALLING J BAKER S COLTMAN C VONHOFF D ROWINSKY E
Citation: L. Hammond et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF THE MULTITARGETED ANTIFOLATE (MTA, LY231514) WITH FOLIC-ACID (FA), Annals of oncology, 9, 1998, pp. 620-620

Authors: BRITTEN CD DIAB S HIDALGO M YOUNG R BAKER S RAZVILLAS B AVERBUCH S SMITH M VONHOFF DD ROWINSKY EK
Citation: Cd. Britten et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ZD9331, A NONPOLYGLUTAMINATED THYMIDYLATE SYNTHASE (TS) INHIBITOR, ADMINISTERED ONCE EVERY 3 WEEKS, Annals of oncology, 9, 1998, pp. 622-622

Authors: VILLALONACALERO M ECKHARDT SG WEISS G CAMPBELL E HIDALGO M KRAYNAK M BEIJNEN J JIMENO J VONHOFF D ROWINSKY E
Citation: M. Villalonacalero et al., A PHASE-I AND PHARMACOKINETIC STUDY OF ET-743, A NOVEL DNA MINOR-GROOVE BINDER OF MARINE ORIGIN, ADMINISTERED AS A 1-HOUR INFUSION DAILY X 5 DAYS, Annals of oncology, 9, 1998, pp. 453-453

Authors: ECKHARDT SG THURMAN A KRAYNAK M HIDALGO M HANHAM A VONHOFF DD ROWINSKY EK
Citation: Sg. Eckhardt et al., A PHASE-I AND PHARMACOLOGICAL (PK) STUDY OF VESNARINONE, AN INDUCER OF DIFFERENTIATION AND APOPTOSIS, IN COMBINATION WITH GEMCITABINE, Annals of oncology, 9, 1998, pp. 478-478

Authors: DIAB S BRITTEN C SMITH R ECKHARDT SG BAKER S HAMMOND L SIU L SHARMA S HIDALGO M AYLESWORTH C YOUNG R WONG L RAZVILLAS B KRAYNAK M DOUGLASS E VONHOFF D ROWINSKY E
Citation: S. Diab et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ZD9331, A NOVEL LONG-ACTING THYMIDYLATE SYNTHETASE (TS) INHIBITOR, ON A SINGLE DOSING EVERY 3 WEEKS SCHEDULE, Annals of oncology, 9, 1998, pp. 611-611

Authors: HAMMOND L BAKER SD VILLALONACALERO M ECKHARDT SG DRENGLER R AYLESWORTH C JOHNSON T HIDALGO M RODRIGUEZ G DIAB S MONROE P THORNTON D JOHNSON R VONHOFF D ROWINSKY E
Citation: L. Hammond et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF THE MULTITARGETED ANTIFOL(MTA) LY231514 WITH FOLIC-ACID (FA), Annals of oncology, 9, 1998, pp. 612-612

Authors: HIDALGO M VILLALONACALERO MA BRITTEN C SIU L DRENGLER R HAMMOND L DIAB S CAMPBELL E LOUIE A ONEIL J VONHOFF D ROWINSKY E
Citation: M. Hidalgo et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF PN401 AS A RESCUE AGENT FOR ESCALATING DOSES OF 5-FLUOROURACIL (5-FU) IN PATIENTS WITH CANCER, Annals of oncology, 9, 1998, pp. 625-625

Authors: GOMEZ H HIDALGO M CASANOVA L COLOMER R PEN DLK OTERO J RODRIGUEZ W CARRACEDO C CORTESFUNES H VALLEJOS C
Citation: H. Gomez et al., RISK-FACTORS FOR TREATMENT-RELATED DEATH IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - RESULTS OF A MULTIVARIATE-ANALYSIS, Journal of clinical oncology, 16(6), 1998, pp. 2065-2069

Authors: HIDALGO M BELTRAN MI REINECKE H MIJANGOS C
Citation: M. Hidalgo et al., THERMAL AND MECHANICAL-PROPERTIES OF SILANE-CROSS-LINKED POLY(VINYLCHLORIDE), Journal of applied polymer science, 70(5), 1998, pp. 865-872

Authors: HIDALGO M MENDIOLA C LOPEZVEGA JM CASTELLANO D MENDEZ M BATISTEALENTON E LOPEZBREA M BELON J BATISTA JN CORTESFUNES H
Citation: M. Hidalgo et al., A MULTICENTER RANDOMIZED PHASE-II TRIAL OF GRANULOCYTE-COLONY-STIMULATING FACTOR-SUPPORTED, PLATINUM-BASED CHEMOTHERAPY WITH FLEXIBLE MIDCYCLE CISPLATIN ADMINISTRATION IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA, Cancer, 83(4), 1998, pp. 719-725

Authors: LOPEZ D REINECKE H HIDALGO M MIJANGOS C
Citation: D. Lopez et al., VINYLCHLORIDE COPOLYMERS OBTAINED BY CHEMICAL MODIFICATION OF PVC, Polymer international, 44(1), 1997, pp. 1-10

Authors: HIDALGO M PAZARES L RIVERA F LIANES P HUIDOBRO G RUIZ A LOPEZBREA M SANZORTIZ J LOPEZ JL CORTESFUNES H TABERNERO JM
Citation: M. Hidalgo et al., MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMORS (MNSGCT) TREATED WITH CISPLATIN-BASED COMBINATION CHEMOTHERAPY, Annals of oncology, 8(6), 1997, pp. 555-559

Authors: GARCIACARBONERO R HIDALGO M PAZARES L CALZAS J GOMEZ H GUERRA JA HITT R HORNEDO J COLOMER R CORTESFUNES H
Citation: R. Garciacarbonero et al., PATIENT SELECTION IN HIGH-DOSE CHEMOTHERAPY TRIALS - RELEVANCE IN HIGH-RISK BREAST-CANCER, Journal of clinical oncology, 15(10), 1997, pp. 3178-3184

Authors: CHEVALIER Y HIDALGO M CAVAILLE JY CABANE B
Citation: Y. Chevalier et al., SMALL-ANGLE NEUTRON-SCATTERING STUDIES OF COMPOSITE LATEX FILM STRUCTURE, Progress in organic coatings, 32(1-4), 1997, pp. 35-41

Authors: WASSERMAN E HIDALGO M HORNEDO J CORTESFUNES H
Citation: E. Wasserman et al., OCTREOTIDE (SMS 201-995) FOR HEMATOPOIETIC SUPPORT-DEPENDENT HIGH-DOSE CHEMOTHERAPY (HSD-HDC)-RELATED DIARRHEA - DOSE-FINDING STUDY AND EVALUATION OF EFFICACY, Bone marrow transplantation, 20(9), 1997, pp. 711-714

Authors: HITT R PAZARES L HIDALGO M COLOMER R BRANDARIZ A PENA M ALVAREZVICENT J HORNEDO J CORTESFUNES H
Citation: R. Hitt et al., PHASE-I PHASE-II STUDY OF PACLITAXEL CISPLATIN AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED HEAD AND NECK-CANCER/, Seminars in oncology, 24(6), 1997, pp. 20-24

Authors: HITT R HORNEDO J COLOMER R HIDALGO M BRANDARIZ A PENA M VICENT JA CORTESFUNES H
Citation: R. Hitt et al., STUDY OF ESCALATING DOSES OF PACLITAXEL PLUS CISPLATIN IN PATIENTS WITH INOPERABLE HEAD AND NECK-CANCER, Seminars in oncology, 24(1), 1997, pp. 58-64

Authors: HIDALGO M HORNEDO J LUMBRERAS C TRIGO JM GOMEZ C PEREA S RUIZ A HITT R CORTESFUNES H
Citation: M. Hidalgo et al., LACK OF ABILITY OF CIPROFLOXACIN-RIFAMPIN PROPHYLAXIS TO DECREASE INFECTION-RELATED MORBIDITY IN NEUTROPENIC PATIENTS GIVEN CYTOTOXIC THERAPY AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 1175-1177

Authors: HIDALGO M
Citation: M. Hidalgo, SPANISH IN 4 CONTINENTS - STUDIES IN LANGUAGE CONTACT AND BILINGUALISM - SILVACORVALAN,C, Language in society, 26(3), 1997, pp. 453-456

Authors: HIDALGO M
Citation: M. Hidalgo, EXPOSING PREJUDICE - PUERTO-RICAN EXPERIENCES OF LANGUAGE, RACE, AND CLASS - URCIUOLI,B, Anthropological quarterly, 70(4), 1997, pp. 199-200

Authors: OMENETTO N CAVALLI P HIDALGO M PETRUCCI GA
Citation: N. Omenetto et al., LASER-INDUCED PHOTOFRAGMENTATION AND FLUORESCENCE SPECTROSCOPY - TOOLS FOR STUDYING ATMOSPHERIC CHEMICAL-REACTIONS AND AEROSOLS, Annali di chimica, 87(3-4), 1997, pp. 241-253

Authors: FONTAS C ANTICO E SALVADO V VALIENTE M HIDALGO M
Citation: C. Fontas et al., CHEMICAL PUMPING OF RHODIUM BY A SUPPORTED LIQUID MEMBRANE CONTAININGALIQUAT 336 AS CARRIER, Analytica chimica acta, 346(2), 1997, pp. 199-206
Risultati: 1-25 | 26-50 | 51-55